Process for preparing BTK inhibitors
US12084454B2 · kind B2 · utility
0Cited by
3References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 3, 2023 |
| Grant date | Sep 10, 2024 |
| Priority date | — |
| Expiry date | Nov 3, 2043 |
Classification
- Technology area (CPC B)Performing Operations; Transporting
- CPC primaryB01J2531/824
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Methods for preparing the Bruton's Tyrosine Kinase (“BTK”) inhibitor compound 2-{3′-hydroxymethyl-1-methyl-5-[5-((S)-2-methyl-4-oxetan-3-yl-piperazin-1-yl)-pyridin-2-ylamino]-6-oxo-1,6-dihydro-[3,4′]bipyridinyl-2′-yl}-7,7-dimethyl-3,4,7,8-tetrahydro-2H,6H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1-one are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.